Literature DB >> 26063238

Early Defensive Mechanisms against Human Papillomavirus Infection.

Andrea Moerman-Herzog1, Mayumi Nakagawa2.   

Abstract

Cervical cancer is the fourth most common cancer in women and is almost exclusively caused by human papillomavirus (HPV) infection. HPV is also frequently associated with other cancers arising from mucosal epithelium, including anal and oropharyngeal cancers, which are becoming more common in both men and women. Viral persistence and progression through precancerous lesion stages are prerequisites for HPV-associated cancer and reflect the inability of cell-mediated immune mechanisms to clear infections and eliminate abnormal cells in some individuals. Cell-mediated immune responses are initiated by innate pathogen sensing and subsequent secretion of soluble immune mediators and amplified by the recruitment and activation of effector T lymphocytes. This review discusses early defensive mechanisms of innate responders to natural HPV infection, their influence on response polarization, and the underappreciated role of keratinocytes in this process.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26063238      PMCID: PMC4519724          DOI: 10.1128/CVI.00223-15

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  93 in total

1.  Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction.

Authors:  P L Vieira; E C de Jong; E A Wierenga; M L Kapsenberg; P Kaliński
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

Review 2.  Cell-mediated immune response to human papillomavirus infection.

Authors:  M Scott; M Nakagawa; A B Moscicki
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

Review 3.  Dendritic cell biology and regulation of dendritic cell trafficking by chemokines.

Authors:  C Caux; S Ait-Yahia; K Chemin; O de Bouteiller; M C Dieu-Nosjean; B Homey; C Massacrier; B Vanbervliet; A Zlotnik; A Vicari
Journal:  Springer Semin Immunopathol       Date:  2000

4.  Cd40 expression in uterine tissues: a key regulator of cytokine expression by fibroblasts.

Authors:  A E King; R W Kelly; H O Critchley; A Malmstrom; M Sennstrom; R P Phipps
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

5.  Intercellular adhesion molecule 1 is critical for activation of CD28-deficient T cells.

Authors:  J L Gaglia; E A Greenfield; A Mattoo; A H Sharpe; G J Freeman; V K Kuchroo
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

6.  Active squamous metaplasia of the cervical epithelium is associated with subsequent acquisition of human papillomavirus 16 infection among healthy young women.

Authors:  Loris Y Hwang; Yifei Ma; Stephen C Shiboski; Sepideh Farhat; Janet Jonte; Anna-Barbara Moscicki
Journal:  J Infect Dis       Date:  2012-06-13       Impact factor: 5.226

7.  Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial.

Authors:  Christoph Grimm; Stephan Polterauer; Camilla Natter; Jasmin Rahhal; Lukas Hefler; Clemens B Tempfer; Georg Heinze; Georg Stary; Alexander Reinthaller; Paul Speiser
Journal:  Obstet Gynecol       Date:  2012-07       Impact factor: 7.661

Review 8.  Therapy of human papillomavirus-related disease.

Authors:  Peter L Stern; Sjoerd H van der Burg; Ian N Hampson; Thomas R Broker; Alison Fiander; Charles J Lacey; Henry C Kitchener; Mark H Einstein
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

9.  Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.

Authors:  Ahmedin Jemal; Edgar P Simard; Christina Dorell; Anne-Michelle Noone; Lauri E Markowitz; Betsy Kohler; Christie Eheman; Mona Saraiya; Priti Bandi; Debbie Saslow; Kathleen A Cronin; Meg Watson; Mark Schiffman; S Jane Henley; Maria J Schymura; Robert N Anderson; David Yankey; Brenda K Edwards
Journal:  J Natl Cancer Inst       Date:  2013-01-07       Impact factor: 13.506

10.  E-cadherin interactions are required for Langerhans cell differentiation.

Authors:  Nobuko Mayumi; Eri Watanabe; Yoshihiko Norose; Eiji Watari; Seiji Kawana; Teunis B H Geijtenbeek; Hidemi Takahashi
Journal:  Eur J Immunol       Date:  2012-12-11       Impact factor: 5.532

View more
  17 in total

1.  Mouse papillomavirus infections spread to cutaneous sites with progression to malignancy.

Authors:  Nancy M Cladel; Lynn R Budgeon; Timothy K Cooper; Karla K Balogh; Neil D Christensen; Roland Myers; Vladimir Majerciak; Deanna Gotte; Zhi-Ming Zheng; Jiafen Hu
Journal:  J Gen Virol       Date:  2017-10       Impact factor: 3.891

Review 2.  Pathogenic Role of Immune Evasion and Integration of Human Papillomavirus in Oropharyngeal Cancer.

Authors:  Takashi Hatano; Daisuke Sano; Hideaki Takahashi; Nobuhiko Oridate
Journal:  Microorganisms       Date:  2021-04-21

3.  Elevation of cervical C-X-C motif chemokine ligand 10 levels is associated with HIV-1 acquisition in pregnant and postpartum women.

Authors:  Michelle C Sabo; Dara A Lehman; Jillian C Pintye; Bingjie Wang; Alison L Drake; John Kinuthia; Lusi Osborn; Daniel Matemo; Barbra A Richardson; Julie Overbaugh; Grace John-Stewart; Susan M Graham
Journal:  AIDS       Date:  2020-10-01       Impact factor: 4.632

Review 4.  Barriers to a cure for HIV in women.

Authors:  Sara Gianella; Athe Tsibris; Liz Barr; Catherine Godfrey
Journal:  J Int AIDS Soc       Date:  2016-02-18       Impact factor: 5.396

5.  Mouse papillomavirus infection persists in mucosal tissues of an immunocompetent mouse strain and progresses to cancer.

Authors:  Nancy M Cladel; Lynn R Budgeon; Karla K Balogh; Timothy K Cooper; Sarah A Brendle; Neil D Christensen; Todd D Schell; Jiafen Hu
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

6.  Human beta-defensin 3 contributes to the carcinogenesis of cervical cancer via activation of NF-κB signaling.

Authors:  Dan Xu; Bing Zhang; Chongbing Liao; Wei Zhang; Weijia Wang; Ying Chang; Yongping Shao
Journal:  Oncotarget       Date:  2016-11-15

Review 7.  Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.

Authors:  Marconi Rego Barros; Talita Helena Araújo de Oliveira; Cristiane Moutinho Lagos de Melo; Aldo Venuti; Antonio Carlos de Freitas
Journal:  J Immunol Res       Date:  2018-05-02       Impact factor: 4.818

Review 8.  Activities of stromal and immune cells in HPV-related cancers.

Authors:  Marconi Rego Barros; Cristiane Moutinho Lagos de Melo; Maria Luiza Carneiro Moura Gonçalves Rego Barros; Rita de Cássia Pereira de Lima; Antonio Carlos de Freitas; Aldo Venuti
Journal:  J Exp Clin Cancer Res       Date:  2018-07-05

Review 9.  New Insights in the Pathogenesis of HPV Infection and the Associated Carcinogenic Processes: The Role of Chronic Inflammation and Oxidative Stress.

Authors:  Simona Roxana Georgescu; Cristina Iulia Mitran; Madalina Irina Mitran; Constantin Caruntu; Maria Isabela Sarbu; Clara Matei; Ilinca Nicolae; Sandra Milena Tocut; Mircea Ioan Popa; Mircea Tampa
Journal:  J Immunol Res       Date:  2018-08-27       Impact factor: 4.818

10.  Substantial Decline in Prevalence of Vaccine-Type and Nonvaccine-Type Human Papillomavirus (HPV) in Vaccinated and Unvaccinated Girls 5 Years After Implementing HPV Vaccine in Norway.

Authors:  Berit Feiring; Ida Laake; Irene Kraus Christiansen; Mona Hansen; Jeanette Stålcrantz; Ole Herman Ambur; Per Magnus; Christine Monceyron Jonassen; Lill Trogstad
Journal:  J Infect Dis       Date:  2018-11-05       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.